One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Changes at Pediatric Nephrology for 2024 and beyond
Changes at Pediatric Nephrology for 2024 and beyond
doi : 10.1007/s00467-023-06215-2
Volume 39, Issue 1
Isotonic versus hypotonic intravenous maintenance fluid therapy: what’s new?
Kenichiro Miura & Roberto Dall’Amico
Hypertension in Wilms tumor
Wendy Hsiao, Michelle Denburg & Benjamin Laskin
Chronic kidney disease–associated pruritus: what is known and its application in children
Shweta Shah, Elizabeth Onugha & Sarah J. Swartz
Long-term treatment of chronic kidney disease patients with anemia using hypoxia-inducible factor prolyl hydroxylase inhibitors: potential concerns
Jia He, Zhanjun Jia, Aihua Zhang & Mi Bai
Incremental dialysis: review of the literature with pediatric perspective
Raj Munshi & Sarah J. Swartz
Efficacy and safety of isotonic versus hypotonic intravenous maintenance fluids in hospitalized children: an updated systematic review and meta-analysis of randomized controlled trials
Basma Ehab Amer, Omar Ahmed Abdelwahab, Ahmed Abdelaziz, Youssef Soliman, Ahmed Mostafa Amin, Maged Ahmed Mohamed, Khaled Albakri, Esraa Mohamed Zedan & Naema Hamouda
Therapeutic drug monitoring in childhood idiopathic nephrotic syndrome: a state of the art review
Fiona Fung-yee Lai, Eugene Yu-hin Chan, Kjell Tullus & Alison Lap-tak Ma
Use of extracorporeal therapies to treat life-threatening intoxications
Kyle Deville1 · Nathan Charlton2 · David Askenazi
New perspectives in pediatric dialysis technologies: the case for neonates and infants with acute kidney injury
Mattia Parolin, Giovanni Ceschia & Enrico Vidal
Hyporeninemic hypoaldosteronism in RMND1-related mitochondrial disease
Martin Kömhoff, Valentina Gracchi, Henry Dijkman, Bodo B. Beck & Leo Monnens
Impact of kidney biopsy on deciding when to initiate enzyme replacement therapy in children with Fabry disease
Jenny Avarappattu, Ariana Gaspert, Giuseppina Spartà & Marianne Rohrbach
Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1
David J. Sas, Kristin Mara, Ramila A. Mehta, Barbara M. Seide, Carly J. Banks, David S. Danese, Tracy L. McGregor, John C. Lieske & Dawn S. Milliner
Novel variants in CRB2 targeting the malfunction of slit diaphragm related to focal segmental glomerulosclerosis
Qing Yang, Dan Tang, Chun Gan, Mi Bai, Xiaomei Song, Wei Jiang, Qiu Li, Yaxi Chen, Aihua Zhang & Mo Wang
Body mass index and implications for pediatric kidney health: a cross-sectional study with urinary biomarkers
T. D. K. S. C. Gunasekara, P. Mangala C. S. De Silva, E. P. S. Chandana, Sudheera Jayasinghe, Chula Herath, Sisira Siribaddana & Nishad Jayasundara
Tolvaptan and urea in paediatric hyponatraemia
Faidra Veligratli, Demitra Alexandrou, Sarit Shah, Rakesh Amin, Mehul Dattani, Hoong-Wei Gan, Adeola Famuboni, Camilo Lopez-Garcia, Richard Trompeter & Detlef Bockenhauer
The manifestations of metabolic acidosis during acetazolamide treatment in a cohort of pediatric idiopathic intracranial hypertension
Yarden Bulkowstein, Adi Nitzan‑Luques, Aviad Schnapp, Noa Barnoy, Shimon Reif, Tal Gilboa & Oded Volovesky
Cost analysis of telemedicine use in paediatric nephrology—the LMIC perspective
Vishnu Dev, Aliza Mittal, Vibha Joshi, Jitendra K. Meena, Akhil Dhanesh Goel, Siyaram Didel, Puneet Pareek, Sanjeev Misra & Kuldeep Singh
Comparison of clean catch and bag urine using LC–MS/MS proteomics in infants
Richard Klaus, Teresa K. Barth, Axel Imhof, Franziska Thalmeier & Bärbel Lange-Sperandio
Duration of prodromal phase and severity of hemolytic uremic syndrome
Alejandro Balestracci, Luciana Meni Battaglia, Ismael Toledo, Sandra Mariel Martin & Laura Beaudoin
Antihypertensive medication nonadherence and target organ damage in children with chronic kidney disease
Rushelle L. Byfield, Rui Xiao, Daichi Shimbo, Ian M. Kronish, Susan L. Furth, Sandra Amaral & Jordana B. Cohen
Response to oral iron therapy in children with anemia of chronic kidney disease
Kelly Meza, Sharmi Biswas, Chantal Talmor, Kanza Baqai, Dmitry Samsonov, Sonia Solomon & Oleh Akchurin
Malnutrition and protein energy wasting are associated with severity and progression of pediatric chronic kidney disease
Carol L. Shen, Dana Liebstein & Hilda Fernandez
Resource use and costs of transitioning from pediatric to adult care for patients with chronic kidney disease
Daniela Choukair, Susanne Rieger, Dirk Bethe, Dorothea Treiber, Georg F. Hoffmann, Corinna Grasemann, Peter Burgard, Jörg Beimler, Janna Mittnacht & Burkhard Tönshoff
Lipid abnormalities in pediatric kidney transplant recipients on steroid withdrawal maintenance immunosuppression
Emily Zangla, Ruchi Mahajan, Ziou Jiang & Sarah J. Kizilbash
Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin
Hayton Chui, Kelly R. McMahon, Shahrad Rod Rassekh, Kirk R. Schultz, Tom D. Blydt-Hansen, Cherry Mammen, Maury Pinsk, Geoffrey D. E. Cuvelier, Bruce C. Carleton, Ross T. Tsuyuki, Colin J. D. Ross, Prasad Devarajan, Louis Huynh, Mariya Yordanova, Frédérik Crépeau-Hubert, Stella Wang, Vedran Cockovski, Ana Palijan & Michael Zappitelli for the Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group
Predictive ability of 2-h serum neutrophil gelatinase-associated lipocalin for perinatal asphyxia-induced acute kidney injury
Bolanle Idowu Oso, Saheed Babajide A. Oseni, Theophilus Adesola Aladekomo, Tewogbade Adeoye Adedeji & Wasiu Adekunle Olowu
Is the renal score predictive for kidney replacement therapy in pediatric patients with crush syndrome?
Deniz Karakaya, Aysun Çaltık Yılmaz, Tülin Güngör, Bahriye Uzun Kenan, Evra Çelikkaya & Evrim Kargın Çakıcı
A lack of KDIGO guidelines for adolescents and young adults with IgA nephropathy
Angelina Dixon, Eliza Blanchette & Jessica Kendrick
A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance
Ester Conversano, Hanna Debiec, Manuela Colucci, Francesco Emma, Pierre Ronco & Marina Vivarelli
Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy
Elia Balestra, Egidio Barbi, Viola Ceconi, Vittorio Di Maso, Ester Conversano & Marco Pennesi
Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement
Dermot Michael Wildes, Susan Harvey, Caoimhe Suzanne Costigan, Clodagh Sweeney, Éilis Twomey, Atif Awan & Kathleen Mary Gorman
Safety and timeliness of telemedicine initiation of continuous kidney replacement therapy
Michelle C. Starr, Kathleen Altemose, Jessalynn Parsley, Daniel T. Cater, David S. Hains & Danielle E. Soranno
Use of the Seraph® 100 Microbind® Affinity Blood Filter in an adolescent patient with disseminated adenoviral disease
David S. Li, Thomas M. Burke, Jodi M. Smith, Robyn C. Reed, Daryl M. Okamura & Shina Menon
Anti-nephrin antibodies in steroid-sensitive nephrotic syndrome in Japanese children
Tomoko Horinouchi, China Nagano & Andrew J. B. Watts
